Trials / Completed
CompletedNCT05096754
OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 74 (actual)
- Sponsor
- TransMedics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT CAP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OCS Liver | Transplant with an OCS preserved liver. |
Timeline
- Start date
- 2020-02-03
- Primary completion
- 2023-02-02
- Completion
- 2023-02-02
- First posted
- 2021-10-27
- Last updated
- 2023-12-08
Locations
11 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05096754. Inclusion in this directory is not an endorsement.